We are happy to meet in person again and this time in Lugano, Switzerland. Our EVengers team is preparing for the MARVEL project review meeting. Summing up the last 16 months of the project it is worth saying that the achieved results are perfectly aligned with the planned objectives. Nevertheless, we still have 12 months to polish our developments and deliver a multifaceted and versatile platform for scalable EV isolation based on the developed peptide probes with high specificity and stability. Looking forward to the clinical application of our platform in form of a novel kit for diagnostic of bladder cancer and integration of EVs in drug delivery for cardiac repair. Wish us good luck!